Early Effects of Topoisomerase I Inhibition on Rna Polymerase Ii Along Transcribed Genes in Human Cells.
From: Department of Biochemistry, University of Bologna School of Pharmacy, via Irnerio 48, 40126 Bologna, Italy.
Journal of molecular biology
- Publish Date: Mar 2006
- ISSN: 0022-2836
- Volume: 357
- Issue: 1
- Pages: 127-38
- Medium: Print
- Language: English
- Citation (JAMA): Khobta Andriy, Ferri Francesca, Lotito Luca, et al. Early Effects of Topoisomerase I Inhibition on Rna Polymerase Ii Along Transcribed Genes in Human Cells.. J. Mol. Biol. Mar 2006;357:127-38
Abstract
We have determined the early effects of camptothecin and alpha-amanitin on genomic DNA-binding sites of RNA polymerase II (RNAPII), TATA-binding protein (TBP), DNA topoisomerase I (Top1), and histone components in human transcribed loci by chromatin-immunoprecipitation (ChIP). The two agents caused notably different alterations in active chromatin. Camptothecin induced a specific reduction of RNAPII density at promoter pause sites and histone modifications suggesting an increased chromatin accessibility. alpha-Amanitin caused an accumulation of RNAPII at transcribed genes, a reduction of TBP bound to chromatin and a less accessible chromatin structure. Interestingly, RNAPII reduction at promoter pause sites occurred within 5-10min of camptothecin treatment, and was not a response to replication-dependent DNA breaks. ChIP analyses of RNAPII along transcribed genes indicated that RNAPII levels were transiently increased at internal exons, and that camptothecin effects could be fully reversed by DRB, a cdk inhibitor. Top1 was found to be enriched in active chromatin, therefore suggesting that Top1 inhibition at the transcribed template and/or adjacent regulating regions immediately affects RNAPII at active genes. The findings are novel in vivo evidence of camptothecin effects on RNAPII bound to transcribing genomic regions, and are consistent with the hypothesis that Top1 activity can be involved in transcription regulation at the level of promoter clearance.
Mesh Headings (Keywords): Amanitins, Binding Sites, Camptothecin, Chromatin, Cyclin-Dependent Kinases, DNA Topoisomerases, Type I, Enzyme Inhibitors, Hela Cells, Humans, Jurkat Cells, Nucleic Acid Conformation, Promoter Regions (Genetics), RNA Polymerase II, TATA-Box Binding Protein, Transcription, Genetic
Check for Full Text / PubMed Unique Identifier (PMID): 16427078
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.